In adults with acute VTE, apixaban vs. rivaroxaban reduced clinically relevant bleeding at 3 mo.
Where this comes from
- Record sourced from PubMed, PMID 42224693.
- Also identified by DOI 10.7326/ANNALS-26-01793-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text].
Medical subject headings
- Pyrazoles
- Pyridones
- Rivaroxaban
- Hemorrhage
- Venous Thromboembolism
- Anticoagulants
- Factor Xa Inhibitors